Published in N Z Med J on November 25, 2011
Safety of intravenous nitroglycerin after administration of sildenafil citrate to men with coronary artery disease: a double-blind, placebo-controlled, randomized, crossover trial. Crit Care Med (2007) 1.40
Off-label use of quetiapine in New Zealand--a cause for concern? N Z Med J (2011) 1.39
Pharmacokinetics and tolerability of voriconazole and a combination oral contraceptive co-administered in healthy female subjects. Br J Clin Pharmacol (2008) 1.16
Single-dose pharmacokinetics and safety of pegylated interferon-alpha2b in patients with chronic renal dysfunction. J Clin Pharmacol (2002) 1.13
Pharmacokinetic interactions of efavirenz and voriconazole in healthy volunteers. Br J Clin Pharmacol (2008) 1.00
Ribavirin dosing in chronic hepatitis C: application of population pharmacokinetic-pharmacodynamic models. Clin Pharmacol Ther (2002) 0.94
Unexpected effect of rifampin on the pharmacokinetics of linezolid: in silico and in vitro approaches to explain its mechanism. J Clin Pharmacol (2010) 0.93
Ketamine as a new treatment for depression: a review of its efficacy and adverse effects. Aust N Z J Psychiatry (2013) 0.89
Assessment of the pharmacokinetics of co-administered maraviroc and raltegravir. Br J Clin Pharmacol (2010) 0.89
Comparative efficacy of antidepressants in preventing relapse in anxiety disorders - a meta-analysis. J Affect Disord (2009) 0.88
Pharmacokinetics of azithromycin and the combination of ivermectin and albendazole when administered alone and concurrently in healthy volunteers. Am J Trop Med Hyg (2007) 0.88
Study design and patient characteristics and outcome in acute mania clinical trials. Bipolar Disord (2011) 0.87
Mood and pain responses to repeat dose intramuscular ketamine in a depressed patient with advanced cancer. J Palliat Med (2012) 0.87
Anti-anxiety drugs reduce conflict-specific "theta"--a possible human anxiety-specific biomarker. J Affect Disord (2012) 0.86
Differential effect of IFNalpha-2b on the cytochrome P450 enzyme system: a potential basis of IFN toxicity and its modulation by other drugs. Clin Cancer Res (2002) 0.86
Dose- and exposure-response to ketamine in depression. Biol Psychiatry (2011) 0.85
Effects of standard and supratherapeutic doses of nelfinavir on cardiac repolarization: a thorough QT study. J Clin Pharmacol (2009) 0.85
Comparative efficacy and acceptability of mood stabilizer and second generation antipsychotic monotherapy for acute mania--a systematic review and meta-analysis. J Affect Disord (2010) 0.84
Bioavailability of amlodipine besylate/atorvastatin calcium combination tablet. J Clin Pharmacol (2006) 0.84
Comparison of pharmacokinetic variability of fesoterodine vs. tolterodine extended release in cytochrome P450 2D6 extensive and poor metabolizers. Br J Clin Pharmacol (2011) 0.84
Pilot dose-response trial of i.v. ketamine in treatment-resistant depression. World J Biol Psychiatry (2014) 0.84
A meta-analysis of the placebo response in antimuscarinic drug trials for overactive bladder. BMC Med Res Methodol (2009) 0.84
Oral bioavailability of desloratadine is unaffected by food. Clin Pharmacokinet (2002) 0.83
Optimal treatment of social phobia: systematic review and meta-analysis. Neuropsychiatr Dis Treat (2012) 0.83
The effect of azithromycin on ivermectin pharmacokinetics--a population pharmacokinetic model analysis. PLoS Negl Trop Dis (2008) 0.82
Factors associated with hospitalization of adult psychiatric patients: cluster analysis. Australas Psychiatry (2013) 0.82
The pharmacokinetic profile of fesoterodine 8 mg with daytime or nighttime dosing. Eur J Clin Pharmacol (2009) 0.81
Exploring the influence of renal dysfunction on the pharmacokinetics of ribavirin after oral and intravenous dosing. Drug Discov Ther (2014) 0.81
Pharmacokinetics of dexrazoxane in subjects with impaired kidney function. J Clin Pharmacol (2010) 0.81
Single-dose pharmacokinetics and tolerability of pegylated interferon-alpha2b in young and elderly healthy subjects. Br J Clin Pharmacol (2003) 0.81
Pharmacokinetics and safety of single-dose ribavirin in patients with chronic renal impairment. Drug Discov Ther (2013) 0.81
The effect of food on the absorption of oral ziprasidone. Psychopharmacol Bull (2007) 0.80
The impact of calories and fat content of meals on oral ziprasidone absorption: a randomized, open-label, crossover trial. J Clin Psychiatry (2008) 0.80
Pharmacokinetics, safety, and tolerability of ribavirin in hemodialysis-dependent patients. Eur J Clin Pharmacol (2011) 0.80
Effect of food on the bioavailability of amlodipine besylate/atorvastatin calcium combination tablet. J Clin Pharmacol (2006) 0.80
Switching from quetiapine to ziprasidone: a sixteen-week, open-label, multicenter study evaluating the effectiveness and safety of ziprasidone in outpatient subjects with schizophrenia or schizoaffective disorder. J Psychiatr Pract (2011) 0.78
Influence of CYP2C19 polymorphism on the pharmacokinetics of nelfinavir and its active metabolite. Br J Clin Pharmacol (2009) 0.78
Demography of medical students at the University of Otago, 2004-2008: a changing spectrum? N Z Med J (2013) 0.78
Quantification of brain voriconazole levels in healthy adults using fluorine magnetic resonance spectroscopy. Antimicrob Agents Chemother (2013) 0.78
'Violence is not part of our job': a thematic analysis of psychiatric mental health nurses' experiences of patient assaults from a New Zealand perspective. Issues Ment Health Nurs (2014) 0.78
Bayesian analysis of posttest predictive value of screening instruments for the psychosis high-risk state. JAMA Psychiatry (2013) 0.77
An eight-week trial investigating the efficacy and tolerability of atorvastatin for children and adolescents with heterozygous familial hypercholesterolemia. Pediatr Cardiol (2011) 0.77
Effect of ziprasidone dose on all-cause discontinuation rates in acute schizophrenia and schizoaffective disorder: a post-hoc analysis of 4 fixed-dose randomized clinical trials. Schizophr Res (2009) 0.76
Case report: long-term mood response to repeat dose intramuscular ketamine in a depressed patient with advanced cancer. J Palliat Med (2013) 0.76
Comparative efficacy of anti-manic drugs in acute mania. Lancet (2012) 0.75
Anterior Cingulate Implant for Alcohol Dependence: Case Report. Neurosurgery (2016) 0.75
Considerations for the design and conduct of a pharmacovigilance study involving mass drug administration in a resource-constrained setting. PLoS Negl Trop Dis (2010) 0.75
Bioavailability of amlodipine besylate following oral administration as a tablet dispersed in applesauce. J Clin Pharmacol (2005) 0.75
Postgraduation retention of medical students from Otago and Auckland medical programmes. N Z Med J (2014) 0.75
Risk management and clinical practice. N Z Med J (2015) 0.75
Do all antidepressants cause QT prolongation--how good is the evidence? N Z Med J (2013) 0.75
Factors related to postgraduate retention of medical graduates in New Zealand. N Z Med J (2013) 0.75